Quantitative analysis of CDX2 protein expression improves its clinical utility as a prognostic biomarker in stage II and III colon cancer - European Journal of Cancer
Genes | Free Full-Text | Cdx2 Animal Models Reveal Developmental Origins of Cancers | HTML
Impact of CDX2 expression status on the survival of patients after curative resection for colorectal cancer liver metastasis | BMC Cancer | Full Text
ARE CDX2, BETA-CATENIN AND WNT IMMUNOMARCHERS USEFUL FOR EVALUATING THE CHANCE OF DISEASE PROGRESSION OR EVOLUTION TO DEATH IN P
A panel of intestinal differentiation markers (CDX2, GPA33, and LI-cadherin) identifies gastric cancer patients with favourable prognosis | SpringerLink
Pathology Outlines - CDX2
Combination of CDX2 H-score quantitative analysis with CD3 AI-guided analysis identifies patients with a good prognosis only in stage III colon cancer - European Journal of Cancer
Bergen Open Research Archive: CDX2: A Prognostic Marker in Metastatic Colorectal Cancer Defining a Better BRAF Mutated and a Worse KRAS Mutated Subgroup
CDH17 – Improved sensitivity & specifi city for identifi cation of colon and stomach adenocarcinomas - Biocare Medical
Frontiers | CDX2: A Prognostic Marker in Metastatic Colorectal Cancer Defining a Better BRAF Mutated and a Worse KRAS Mutated Subgroup
Prognostic value of low CDX2 expression in colorectal cancers with a high stromal content – a short report | SpringerLink
CDX2, CK7 and CK20 staining in distant metastases of | Download Table
CDX1 and CDX2 immunohistochemistry and image analysis at different... | Download Scientific Diagram
Gastric-immunophenotype tumour end with CDX2 expression. Tumour cells... | Download Scientific Diagram
Cdx2 Protein Expression in Normal and Malignant Human Tissues: An Immunohistochemical Survey Using Tissue Microarrays | Modern Pathology
Loss of CDX2 expression is associated with poor prognosis in colorectal cancer patients
CDX2 - an overview | ScienceDirect Topics
CDX2 Expression in Cutaneous Metastatic Carcinomas and Extramammary Paget's Disease | Anticancer Research
Bergen Open Research Archive: Predictive and prognostic markers in localized colon cancer : with emphasis on the biomarkers maspin, mismatch repair deficiency, CDX2, tumor grade, PD-L1, and tumor-infiltrating lymphocytes.
Prognostic, predictive, and pharmacogenomic assessments of CDX2 refine stratification of colorectal cancer - Bruun - 2018 - Molecular Oncology - Wiley Online Library
CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer | NEJM
Examples of CDX2 expression. a Positive nuclear CDX2 expression in all... | Download Scientific Diagram
Pathology Outlines - CDX2
Cancers | Free Full-Text | Immunohistochemistry for Diagnosis of Metastatic Carcinomas of Unknown Primary Site | HTML
The homeobox intestinal differentiation factor CDX2 is selectively expressed in gastrointestinal adenocarcinomas | Modern Pathology
CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon Cancer. - Abstract - Europe PMC
